New Leaf Venture Partners as of Sept. 30, 2016
Portfolio Holdings for New Leaf Venture Partners
New Leaf Venture Partners holds 14 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 18.3 | $26M | 784k | 32.47 | |
| Versartis | 18.0 | $25M | 2.0M | 12.25 | |
| Edge Therapeutics | 17.6 | $24M | 2.3M | 10.41 | |
| Oxford Immunotec Global | 12.5 | $17M | 1.4M | 12.56 | |
| Dimension Therapeutics | 11.8 | $17M | 2.1M | 7.99 | |
| Alder Biopharmaceuticals | 5.5 | $7.6M | 231k | 32.77 | |
| Dermira | 4.7 | $6.6M | 194k | 33.82 | |
| Sage Therapeutics (SAGE) | 4.4 | $6.1M | 133k | 46.05 | |
| Dynavax Technologies (DVAX) | 3.0 | $4.2M | 400k | 10.49 | |
| AVEO Pharmaceuticals | 1.7 | $2.3M | 2.6M | 0.89 | |
| Vistagen Therapeutics | 1.1 | $1.5M | 353k | 4.23 | |
| Trillium Therapeutics, Inc. Cmn | 0.9 | $1.2M | 81k | 14.77 | |
| Inotek Pharmaceuticals | 0.3 | $477k | 50k | 9.48 | |
| Adaptimmune Therapeutics (ADAP) | 0.3 | $388k | 55k | 7.05 |
